WallStreetZenWallStreetZen

NASDAQ: PCSA
Processa Pharmaceuticals Inc Stock Ownership - Who owns Processa Pharmaceuticals?

Insider buying vs selling

Have Processa Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
David 1. YoungPres. Research Development2024-02-0721,000$2.45
$51.53kBuy
David 1. YoungPres. Research Development2024-02-0620,000$2.53
$50.50kBuy
Patrick LinChief Business - Strategy Off2024-02-011,500$2.40
$3.60kBuy
Patrick LinChief Business - Strategy Off2024-01-312,500$2.37
$5.93kBuy
George K. NgChief Executive Officer2024-01-3010,000$2.70
$27.00kBuy
Justin W. YorkeDirector2024-01-308,000$2.69
$21.54kBuy
Justin W. YorkeDirector2023-10-126,000$0.30
$1.80kBuy
Patrick LinChief Business - Strategy Off2023-10-125,000$0.32
$1.60kBuy
George K. NgChief Executive Officer2023-10-12100,000$0.25
$25.00kBuy
James H. StankerChief Financial Officer2023-10-1215,000$0.33
$4.95kBuy

1 of 3

PCSA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PCSA insiders and whales buy or sell their stock.

PCSA Shareholders

What type of owners hold Processa Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
James E. Besser118.41%1,458,300$3.31MInsider
Justin W. Yorke90.26%1,111,649$2.52MInsider
Sian Bigora43.55%536,372$1.22MInsider
Wendy Guy29.98%369,208$838.10kInsider
Citadel Advisors LLC25.61%315,410$715.98kInstitution
Virgil Thompson19.55%240,755$546.51kInsider
Vanguard Group Inc19.05%234,653$532.66kInstitution
George K. Ng17.86%220,000$499.40kInsider
Khalid Islam15.70%193,395$439.01kInsider
Robert Michael Floyd13.97%172,061$390.58kInsider

1 of 3

PCSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PCSA19.50%80.50%Net BuyingNet Buying
ONCO12.98%25.57%
FWBI0.08%99.92%Net SellingNet Selling
BPTH3.24%96.76%
CYCC1.23%98.77%Net Buying

Processa Pharmaceuticals Stock Ownership FAQ

Who owns Processa Pharmaceuticals?

Processa Pharmaceuticals (NASDAQ: PCSA) is owned by 91.81% institutional shareholders, 379.04% Processa Pharmaceuticals insiders, and 0.00% retail investors. James E. Besser is the largest individual Processa Pharmaceuticals shareholder, owning 1.46M shares representing 118.41% of the company. James E. Besser's Processa Pharmaceuticals shares are currently valued at $3.45M.

If you're new to stock investing, here's how to buy Processa Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.